Company: CRAC
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001213900-25-049453
Chunk: 135

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-05-30
Form: S-1
Chunk 135
---
 disclosure that may be required of non -emerginggrowth public companies under the Dodd -FrankWall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier. 89 PROPOSED BUSINESS General We are a blank check company incorporated on April 29, 2025 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. Purpose Crown Reserve Acquisition Corp. I intends to identify and acquire a business within an industry or sector that complements the experience of our management team and can benefit from our operational expertise. We will have a generalist approach to industry sectors, but with particular emphasis on industries where we have core competencies and experiences, such as pharma, medical technology and medical equipment, and healthcare IT industries. Our Leadership Our management team and board consist of seasoned industry executives that possess deep collective understanding of various industries, including the pharma, medical technology and medical equipment, and healthcare IT industries, as well as the evolution of these sectors and market opportunities. Management Team Prashant Patel(age: 51) serves as Chairman and Chief Executive Officer. Mr. Patel currently serves on the board of Eulogistic Health Inc. (NASDAQ:WGRX) and has previously served on the boards of Trxade Health Inc. (NASDAQ:MEDS) and Sceinture Holdings Inc. (NASDAQ:SCNX). Additionally, Mr. Patel has been a board advisor to several special purpose acquisition companies over the years including